The U.S. Food and Drug Administration (FDA) has issued three letters (one warning letter and two untitled letters) over the last two months of 2019 directed at four different companies focused on the processing, distributing,...more
1/15/2020
/ Biologics ,
Distributors ,
FDA Warning Letters ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Manufacturer Liability ,
Marketing ,
Pharmaceutical Industry ,
Public Health Service Act ,
Regenerative Medicine ,
Regulatory Requirements ,
Stem cells